| Accession | SAMC1650949 |
|---|---|
| Accession in Other Database | GSA-Human: HRS161420 |
| Sample name | ST_IP_rep1 |
| Title | ST_IP_rep1_MeRIP |
| Sample type | Human sample |
| Organism | Homo sapiens |
| Description | IP of ST-treated endothelial cells(ECs), MeRIP-seq,rep1 |
| Attributes | *Only part of the sample information is displayed on this page because the related dataset HRA000760 has not yet been registered in the Human Genetic Resource Management Platform of MOST. |
| Release date | 2022-04-16 |
| BioProject Accession | PRJCA004746 |
| Submitter | Liu Meng Mengxia (yingyang@big.ac.cn) |
| Organization | BIG |
| Submission date | 2023-06-18 |
| Resource name | Description |
|---|---|
| GSA-Human (1) | - |
| HRA000760 (Open Access) | N6-methyladenosine (m6A) is the most prevalent internal modification for eukaryotic mRNA, but its function in endothelial atherogenic progress remains unclear. Here, we performed the RNA-seq and MeRIP-seq analysis of the regulation of m6A in atherosclerosis process using endothelial cells treated with ST and oscillatory stress (OS). |